34 years treating AML
Dr. Tallman's research is focused on developing novel treatments using drugs that target specific molecular genetic abnormalities in leukemia cells. He is particularly sensitive to the importance of developing new treatments for older adults with leukemia, treatments that are more specific to the leukemia cell and therefore will be less toxic to normal cells so that patients have fewer side effects.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.
Terms of Use and Privacy Policy Newsroom About Donations Find an AML Specialist Newsletter Learn Connect
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811